Risk Prediction of a Multiple Sclerosis Diagnosis

Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system. The progression and severity of MS varies by individual, but it is generally a disabling disease. Although medications have been developed to slow the disease progression and help manage symptoms, MS research has yet to result in a cure. Early diagnosis and treatment of the disease have been shown to be effective at slowing the development of disabilities. However, early MS diagnosis is difficult because symptoms are intermittent and shared with other diseases. Thus most previous works have focused on uncovering the risk factors associated with MS and predicting the progression of disease after a diagnosis rather than disease prediction. This paper investigates the use of data available in electronic medical records (EMRs) to create a risk prediction model, thereby helping clinicians perform the difficult task of diagnosing an MS patient. Our results demonstrate that even given a limited time window of patient data, one can achieve reasonable classification with an area under the receiver operating characteristic curve of 0.724. By restricting our features to common EMR components, the developed models also generalize to other healthcare systems.

[1]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[2]  C. Wolfson,et al.  Environmental risk factors in multiple sclerosis , 2008, Acta neurologica Scandinavica. Supplementum.

[3]  Raffaello Nemni,et al.  Exploring the predictive value of the evoked potentials score in MS within an appropriate patient population: a hint for an early identification of benign MS? , 2012, BMC Neurology.

[4]  Carlo Berzuini,et al.  Predicting secondary progression in relapsing–remitting multiple sclerosis: a Bayesian analysis , 2001, Journal of the Neurological Sciences.

[5]  B. Weinshenker,et al.  Epidemiology of multiple sclerosis. , 1996, Neurologic clinics.

[6]  Miguel A Hernán,et al.  Recent use of oral contraceptives and the risk of multiple sclerosis. , 2005, Archives of neurology.

[7]  M. Tintoré,et al.  Early onset multiple sclerosis: The role of gender , 2009, Journal of the Neurological Sciences.

[8]  A. Alheraish,et al.  Design and implementation of home automation system , 2004, IEEE Transactions on Consumer Electronics.

[9]  P Laing,et al.  Multiple sclerosis: sunlight, diet, immunology and aetiology. , 1996, Medical hypotheses.

[10]  Amy Perrin Ross,et al.  Recent Developments in the Early Diagnosis and Management of Multiple Sclerosis , 2010, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses.

[11]  S Suissa,et al.  Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group. , 2001, The New England journal of medicine.

[12]  D Spiegelman,et al.  Oral contraceptives and the incidence of multiple sclerosis , 2000, Neurology.

[13]  A. Ascherio,et al.  Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors , 2007, Annals of neurology.

[14]  Peter Vestergaard,et al.  A simple score for estimating the long-term risk of fracture in patients with multiple sclerosis , 2012, Neurology.

[15]  David Aron,et al.  Failure of ICD-9-CM codes to identify patients with comorbid chronic kidney disease in diabetes. , 2006, Health services research.

[16]  E. Kahana Epidemiologic studies of multiple sclerosis: a review. , 2000, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[17]  J. De Pedro-Cuesta,et al.  Predicting multiple sclerosis at optic neuritis onset , 2003, Multiple sclerosis.

[18]  Silvana Quaglini,et al.  Early prediction of the long term evolution of multiple sclerosis: the Bayesian Risk Estimate for Multiple Sclerosis (BREMS) score , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[19]  E Marshall,et al.  A Shadow Falls on Hepatitis B Vaccination Effort , 1998, Science.

[20]  R. Hintzen,et al.  Genetics of multiple sclerosis. , 2011, Biochimica et biophysica acta.

[21]  C. Lucchinetti,et al.  Multiple Sclerosis: Current Pathophysiological Concepts , 2001, Laboratory Investigation.

[22]  Jing Cui,et al.  Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score , 2009, The Lancet Neurology.

[23]  E. Fisher,et al.  The accuracy of Medicare's hospital claims data: progress has been made, but problems remain. , 1992, American journal of public health.

[24]  Rohit Bakshi,et al.  Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale. , 2008, Archives of neurology.

[25]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.

[26]  H H F REESE,et al.  Diagnosis and treatment of multiple sclerosis. , 1949, Postgraduate medicine.

[27]  A. Ascherio,et al.  Environmental risk factors for multiple sclerosis. Part I: The role of infection , 2007, Annals of neurology.

[28]  G Cutter,et al.  Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS , 2001, Neurology.

[29]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[30]  Pierre Grammond,et al.  The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[31]  A M Walker,et al.  Hepatitis B vaccination and the risk of multiple sclerosis. , 2001, The New England journal of medicine.

[32]  Amy,et al.  VACCINATIONS AND THE RISK OF RELAPSE IN MULTIPLE SCLEROSIS , 2022 .

[33]  A. Ascherio,et al.  Epstein–Barr Virus Infection and Multiple Sclerosis: A Review , 2010, Journal of Neuroimmune Pharmacology.

[34]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[35]  John F. Hurdle,et al.  Measuring diagnoses: ICD code accuracy. , 2005, Health services research.

[36]  G. Franklin,et al.  Environmental risk factors in multiple sclerosis , 2003, Neurology.